IMC Chicago
NVS icon

IMC Chicago’s Novartis NVS Stock Holding History

IMC Chicago’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.09M Sell
58,000
-10,600
-15% -$1.59M ﹤0.01% 1610
2026
Q1 		$10.5M Buy
68,600
+3,500
+5% +$537K ﹤0.01% 1223
2025
Q4 		$8.98M Buy
65,100
+2,800
+4% +$367K ﹤0.01% 1305
2025
Q3 		$7.99M Buy
62,300
+25,000
+67% +$3.05M ﹤0.01% 1274
2025
Q2 		$4.51M Sell
37,300
-8,500
-19% -$958K ﹤0.01% 1454
2025
Q1 		$5.11M Buy
45,800
+12,000
+36% +$1.28M ﹤0.01% 1218
2024
Q4 		$3.29M Buy
33,800
+3,700
+12% +$395K ﹤0.01% 1501
2024
Q3 		$3.46M Sell
30,100
-11,000
-27% -$1.25M ﹤0.01% 1330
2024
Q2 		$4.38M Buy
41,100
+18,800
+84% +$1.89M ﹤0.01% 1128
2024
Q1 		$2.16M Buy
22,300
+10,600
+91% +$1.09M ﹤0.01% 1321
2023
Q4 		$1.18M Buy
+11,700
New +$1.13M ﹤0.01% 1378

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

IMC Chicago's NVS Position: Q2 2026 in Review

IMC Chicago opened a new position in Novartis (NVS) in Q2 2026: 9,740 shares worth $1.53M. The stake represents ﹤0.01% of the portfolio and ranks #3343 among its holdings.

1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • IMC Chicago held 9,740 shares of Novartis worth $1.53M as of Q2 2026.
  • Novartis was a new IMC Chicago position in Q2 2026.
  • Novartis made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3343 holding.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.